| Ytd | -44.83% | |
| 1y | -66.57% |
| Open | 0.58 | Prev Close | 0.59 | Low | 0.56 | High | 0.59 | Mkt Cap | 3.46M |
| Vol | 84.99K | Avg Vol | 1.85M | EPS | N/A | P/E | N/A | Forward P/E | 210.67 |
| Beta | 3.67 | Short Ratio | 0.37 | Inst. Own | 5.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-10 | 50-d Avg | 0.66 | 200-d Avg | 0.92 | 1yr Est | 19000.00 |
RDHL News
Together with the previously announced Talicia® strategic divestiture, the acquisition from Ferring
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regul
RedHill Biopharma divests Talicia to Apotex, boosting liquidity and funding its commercial growth st
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-m
EIX: -10% | Edison International shares are trading lower following a report suggesting that Califor
Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company'
Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company's comme
Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market
Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market
The number of confirmed Ebola cases and deaths has increased substantially to 3221 cases and 1407 de
Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market sess
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon
The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opagan
The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opagan
RALEIGH, N.C. and TEL-AVIV, Israel, June 8, 2026 /PRNewswire/ -- RedHill Biopharma Ltd.
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolaviru
Vancouver, BC, May 26, 2026 (GLOBE NEWSWIRE) -- Bessor Minerals Inc. (TSXV:BST) ("Bessor" or the “Co
RHB-2041 is a next-generation optimized formulation of RedHill's oral RHB-104 2 , designed for enhan
2025 was a year of tenacity, strategic transactions and building traction for RedHill Talicia® busin
New preclinical data, independently presented in two posters at the 2026 American Association for Ca
Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF - Get Free Report) and Redhill Biopharma (
Redhill Biopharma Ltd. (NASDAQ: RDHL - Get Free Report)'s stock price crossed below its 200-day movi
The full sales and operational launch of Talicia, under the joint commercialization agreement betwee
Redhill Biopharma Ltd. (NASDAQ: RDHL - Get Free Report) shares crossed below its two hundred day mov
Redhill Biopharma Ltd (NASDAQ: RDHL) stock is trading lower on Tuesday, possibly on profit-taking af
RHB-102 1 is a proprietary, advanced clinical-stage, once-daily, bimodal extended-release, oral tab
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbust
TEL-AVIV, Israel and RALEIGH, N.C. , Dec. 1, 2025 /PRNewswire/ -- RedHill Biopharma Ltd.
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly